DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/43zf57/orphan_drugs) has announced the addition of the "Orphan Drugs - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Orphan Drugs in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020.
The report profiles 142 companies including many key and niche players such as -
- AbbVie, Inc.
- Actelion Pharmaceuticals Ltd.
- Amgen, Inc.
- AstraZeneca Plc
- Bayer HealthCare AG
Key Topics Covered:
I. Introduction, Methodology & Product Definitions
Ii. Executive Summary
1. Industry Overview
2. Orphan Drug FDA Approvals
3. Growth Drivers And Inhibitors
4. Current Market Trends
5. Breakthroughs In Orphan Disease Treatment - A Ray Of Hope
6. Regulatory Scenario
7. Product Overview
8. Product Approvals
9. Recent Industry Activity
10. Focus On Select Players
11. Global Market Perspective
Iv. Competitive Landscape
For more information visit http://www.researchandmarkets.com/research/43zf57/orphan_drugs
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.